Alpha Tau Medical Analyst Ratings
Alpha Tau Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/18/2023 | 150% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/24/2023 | 150% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/18/2023 | 150% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/15/2023 | 150% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 04/24/2023 | 150% | HC Wainwright & Co. | → $9 | Initiates Coverage On | → Buy |
| 11/23/2022 | 233.33% | Piper Sandler | $19 → $12 | Maintains | Overweight |
| 04/14/2022 | 455.56% | Cantor Fitzgerald | → $20 | Initiates Coverage On | → Overweight |
| 04/08/2022 | 427.78% | Piper Sandler | → $19 | Initiates Coverage On | → Overweight |
| 04/04/2022 | 483.33% | Citigroup | → $21 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/18/2023 | 150% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 05/24/2023 | 150% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 05/18/2023 | 150% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 05/15/2023 | 150% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 2023 年 4 月 24 日 | 150% | HC Wainwright & Co. | → 9 美元 | 啓動覆蓋開啓 | → 購買 |
| 2022 年 11 月 23 日 | 233.33% | 派珀·桑德勒 | 19 美元 → 12 美元 | 維護 | 超重 |
| 2022 年 4 月 14 日 | 455.56% | 坎託·菲茨傑拉德 | → 20 美元 | 啓動覆蓋開啓 | → 超重 |
| 04/08/2022 | 427.78% | 派珀·桑德勒 | → 19 美元 | 啓動覆蓋開啓 | → 超重 |
| 2022 年 4 月 4 日 | 483.33% | 花旗集團 | → 21 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Alpha Tau Medical (DRTS)?
Alpha Tau Medical（DRTS）的目標價格是多少？
The latest price target for Alpha Tau Medical (NASDAQ: DRTS) was reported by HC Wainwright & Co. on August 18, 2023. The analyst firm set a price target for $9.00 expecting DRTS to rise to within 12 months (a possible 150.00% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月18日公佈了Alpha Tau Medical（納斯達克股票代碼：DRTS）的最新目標股價。該分析公司將目標股價定爲9.00美元，預計DRTS將在12個月內上漲至150.00％（可能上漲150.00％）。去年有6家分析公司公佈了評級。
What is the most recent analyst rating for Alpha Tau Medical (DRTS)?
Alpha Tau Medical（DRTS）的最新分析師評級是多少？
The latest analyst rating for Alpha Tau Medical (NASDAQ: DRTS) was provided by HC Wainwright & Co., and Alpha Tau Medical reiterated their buy rating.
HC Wainwright & Co. 提供了Alpha Tau Medical（納斯達克股票代碼：DRTS）的最新分析師評級，Alpha Tau Medical重申了買入評級。
When is the next analyst rating going to be posted or updated for Alpha Tau Medical (DRTS)?
Alpha Tau Medical（DRTS）的下一份分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alpha Tau Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alpha Tau Medical was filed on August 18, 2023 so you should expect the next rating to be made available sometime around August 18, 2024.
分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與Alpha Tau Medical的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Alpha Tau Medical的最後一次評級是在2023年8月18日提交的，因此你應該預計下一個評級將在2024年8月18日左右公佈。
Is the Analyst Rating Alpha Tau Medical (DRTS) correct?
分析師對Alpha Tau Medical（DRTS）的評級是否正確？
While ratings are subjective and will change, the latest Alpha Tau Medical (DRTS) rating was a reiterated with a price target of $0.00 to $9.00. The current price Alpha Tau Medical (DRTS) is trading at is $3.60, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但重申了最新的Alpha Tau Medical（DRTS）評級，目標股價爲0.00美元至9.00美元。Alpha Tau Medical（DRTS）目前的交易價格爲3.60美元，在分析師的預測區間內。